SCHEMBL29623213

SCHEMBL29623213

N#Cc1c(Cl)ncnc1NCc1ccccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.52
HTT P42858 2/20 0.52
ALOX15 P16050 2/20 0.52
AURKA O14965 1/20 0.49
RPS6KB1 P23443 1/20 0.49
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPK1 P28482 1/20 0.48
VNN1 O95497 1/20 0.42
MAPT P10636 5/20 0.42
GAA P10253 4/20 0.42
TSHR P16473 2/20 0.42
MAP4K4 O95819 1/20 0.41
PDE5A O76074 1/20 0.41
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
HSD17B10 Q99714 1/20 0.40
ABL1 P00519 2/20 0.40
SRC P12931 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23162568 1.00 LMNA (0.52) LMNAHTTALOX15AURKARPS6KB1
SCHEMBL29623281 0.83 ALDH1A1 (0.54) LMNAHTTALDH1A1KDM4EMAPK1
SCHEMBL23204279 0.83 ALDH1A1 (0.54) LMNAHTTALDH1A1KDM4EMAPK1
SCHEMBL29623143 0.80 MAPT (0.53) LMNAHTTALOX15AURKARPS6KB1
SCHEMBL23162549 0.80 MAPT (0.53) LMNAHTTALOX15AURKARPS6KB1
SCHEMBL4929341 0.78 KDM4C (0.57) LMNAHTTALOX15AURKARPS6KB1
SCHEMBL8243683 0.76 PGK1 (0.41) ALDH1A1KDM4EMAP4K4HSD17B10HPGD
SCHEMBL4267388 0.75 TSHR (0.53) AURKAALDH1A1KDM4EMAPK1MAPT
SCHEMBL23162580 0.75 TAAR1 (0.56) LMNAHTTALDH1A1KDM4EMAPK1
SCHEMBL4261576 0.74 ADRA2A (0.41) LMNAKDM4ETSHRHSD17B10SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4038065-A1 SUBSTITUTED PYRIMIDINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2022-08-10 EP disclosed
CN-114450277-A Substituted pyrimidines for the treatment and prevention of hepatitis B virus infection 豪夫迈·罗氏有限公司 2022-05-06 CN disclosed